CYTOSORBENTS CORP's ticker is and the CUSIP is 23283X956. A total of 3 filers reported holding CYTOSORBENTS CORP in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,000 | -50.0% | 1,300 | +30.0% | 0.00% | – |
| Q2 2022 | $2,000 | – | 1,000 | +900.0% | 0.00% | – |
| Q4 2021 | $0 | -100.0% | 100 | -99.7% | 0.00% | – |
| Q3 2021 | $249,000 | 0.0% | 33,100 | 0.0% | 0.00% | – |
| Q2 2021 | $249,000 | -29.1% | 33,100 | +8072.8% | 0.00% | -100.0% |
| Q1 2021 | $351,000 | +550.0% | 405 | +487.0% | 0.00% | – |
| Q4 2020 | $54,000 | -66.0% | 69 | -65.5% | 0.00% | – |
| Q3 2020 | $159,000 | +10.4% | 200 | +37.0% | 0.00% | – |
| Q2 2020 | $144,000 | -7.1% | 146 | -27.4% | 0.00% | – |
| Q1 2020 | $155,000 | +3000.0% | 201 | +1335.7% | 0.00% | – |
| Q4 2019 | $5,000 | -28.6% | 14 | 0.0% | 0.00% | – |
| Q3 2019 | $7,000 | -63.2% | 14 | -53.3% | 0.00% | – |
| Q2 2019 | $19,000 | +216.7% | 30 | +233.3% | 0.00% | – |
| Q1 2019 | $6,000 | +50.0% | 9 | +80.0% | 0.00% | – |
| Q4 2018 | $4,000 | -88.9% | 5 | -82.1% | 0.00% | – |
| Q3 2018 | $36,000 | +44.0% | 28 | +27.3% | 0.00% | – |
| Q2 2018 | $25,000 | – | 22 | -37.1% | 0.00% | – |
| Q1 2018 | $0 | -100.0% | 35 | -25.5% | 0.00% | – |
| Q4 2017 | $1,000 | -66.7% | 47 | -40.5% | 0.00% | – |
| Q3 2017 | $3,000 | -50.0% | 79 | -30.1% | 0.00% | – |
| Q1 2017 | $6,000 | +50.0% | 113 | +927.3% | 0.00% | – |
| Q3 2015 | $4,000 | +300.0% | 11 | +37.5% | 0.00% | – |
| Q2 2015 | $1,000 | – | 8 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 3,600 | $5,000 | 0.00% |
| SIMPLEX TRADING, LLC | 1,300 | $1,000 | 0.00% |